Screener
Phathom Pharmaceuticals, Inc. PHAT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $865.35M.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
FAQ
- What is Phathom Pharmaceuticals, Inc.'s market capitalization?
- Phathom Pharmaceuticals, Inc. (PHAT) reported market capitalization of $865.35M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s market capitalization increased by 27.0% year-over-year, from $681.39M to $865.35M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s market capitalization has grown at a 2.3% compound annual growth rate (CAGR), from $1.05B to $1.18B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Phathom Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude